Alnylam Pharmaceuticals, Inc.
Oligonucleotide end caps
Last updated:
Abstract:
Modified nucleic acids are described herein, including pharmaceutical compositions comprising the modified nucleic acids, and methods of using the modified nucleic acids.
Status:
Grant
Type:
Utility
Filling date:
25 Oct 2016
Issue date:
20 Aug 2019